Clinical Trial Update: Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation Who Underwent Catheter Ablation [NA]

View source ↗

Summary

This clinical trial update reports on the use of Refralon in patients with recurrent atrial fibrillation (paroxysmal and persistent) after catheter ablation, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Refralon

Snippet

Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | Conditions: Atrium; Fibrillation, Atrium; Flutter | NA | Status: COMPLETED